These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Update in diffuse parenchymal lung disease, 2013. Rosas IO; Kaminski N Am J Respir Crit Care Med; 2015 Feb; 191(3):270-4. PubMed ID: 25635490 [TBL] [Abstract][Full Text] [Related]
6. Two new drugs for idiopathic pulmonary fibrosis. Med Lett Drugs Ther; 2014; 56(1457):123-4. PubMed ID: 25461229 [No Abstract] [Full Text] [Related]
7. [Antifibrotic treatment]. von der Beck D; Löh B; Drakopanagiotakis F; Markart P; Günther A Dtsch Med Wochenschr; 2014 Dec; 139(49):2523-5. PubMed ID: 25423462 [No Abstract] [Full Text] [Related]
8. Therapeutic advances in idiopathic pulmonary fibrosis. George G; Vaid U; Summer R Clin Pharmacol Ther; 2016 Jan; 99(1):30-2. PubMed ID: 26502087 [No Abstract] [Full Text] [Related]
9. Two therapies now available for idiopathic pulmonary fibrosis. Morrow T Manag Care; 2014 Dec; 23(12):47-8. PubMed ID: 25939185 [No Abstract] [Full Text] [Related]
10. FDA panel likes new treatment for idiopathic pulmonary fibrosis. Morrow T Manag Care; 2010 Apr; 19(4):53-4. PubMed ID: 20446566 [No Abstract] [Full Text] [Related]
11. Novel treatments for idiopathic pulmonary fibrosis. Spagnolo P Am J Med; 2015 May; 128(5):447-9. PubMed ID: 25613299 [No Abstract] [Full Text] [Related]
12. Hot off the breath: A big step forward for idiopathic pulmonary fibrosis. Ryerson CJ; Collard HR Thorax; 2014 Sep; 69(9):791-2. PubMed ID: 24996636 [No Abstract] [Full Text] [Related]
13. InterMune and Boehringer blaze trails for idiopathic pulmonary fibrosis drugs. Kingwell K Nat Rev Drug Discov; 2014 Jul; 13(7):483-4. PubMed ID: 24981347 [No Abstract] [Full Text] [Related]
14. [Two new drugs for the treatment of idiopathic lung fibrosis: A new therapeutic era!]. Crestani B Rev Med Interne; 2015 Nov; 36(11):719-21. PubMed ID: 26065328 [No Abstract] [Full Text] [Related]
15. Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions. Raghu G; Selman M Am J Respir Crit Care Med; 2015 Feb; 191(3):252-4. PubMed ID: 25635489 [No Abstract] [Full Text] [Related]
16. Design of Idiopathic Pulmonary Fibrosis Clinical Trials in the Era of Approved Therapies. Kaner RJ; Bajwa EK; El-Amine M; Gorina E; Gupta R; Lazarus HM; Luckhardt TR; Mouded M; Posada K; Richeldi L; Stauffer J; Tutuncu A; Martinez FJ Am J Respir Crit Care Med; 2019 Jul; 200(2):133-139. PubMed ID: 30985215 [No Abstract] [Full Text] [Related]
17. [The Latest Information on Respiratory Disease Management. Topics: III. New Treatment of Idiopathic Pulmonary Fibrosis]. Kashiwada T; Azuma A Nihon Naika Gakkai Zasshi; 2016 Jun; 105(6):970-6. PubMed ID: 30168687 [No Abstract] [Full Text] [Related]
18. Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now? Rangarajan S; Locy ML; Luckhardt TR; Thannickal VJ Drugs; 2016 Mar; 76(3):291-300. PubMed ID: 26729185 [TBL] [Abstract][Full Text] [Related]
19. [Two drugs inhibit disease progression. Idiopathic lung fibrosis treatable for the first time]. Einecke D MMW Fortschr Med; 2015 Feb; 157(2):24-5. PubMed ID: 25743506 [No Abstract] [Full Text] [Related]